Division of Bausch Health Companies Inc.
Latest From eyeonics Inc.
The arrival of a new generation of intraocular lenses and corneal inlays – designed to offer clearer, improved vision without the need for reading glasses – is expected to spur growth in the presbyopia market.
At this year's meeting of the Congress of the European Society of Cataract and Refractive Surgeons, market leaders made headlines with news of joint ventures in refractive surgery, new product launches and re-launches, and other glimpses into the future of vision correction technology.
At this year's American Society of Cataract and Refractive Surgery symposium, enthusiasm over technological advances in nearly every product segment, including presbyopia-correcting IOLs and cataract surgeries, was dampened by the reality of the softening demand for laser vision correction.
The buzz at this year's annual meeting of the American Academy of Ophthalmology focused on two things: the presbyopia-correcting intraocular lens market, and the controversy surrounding the drugs Lucentis and Avastin for treating wet age-related macular degeneration.
- Implantable Devices
Surgical Equipment & Devices
- Minimally or Less Invasive
- Therapeutic Areas
- C&C Vision Inc.
- North America
- Parent & Subsidiaries
- Bausch Health Companies Inc.
- Senior Management
J. Andy Corley, Chmn., Pres. & CEO
Steven J Naber, CFO
J. Michael Judy, VP, Global Mktg. & Intl NA Sales
- Contact Info
Phone: (949) 916-9352
26970 Aliso Viejo Pkwy
Aliso Viejo, CA 92656
All set! This article has been sent to firstname.lastname@example.org.
All fields are required. For multiple recipients, separate email addresses with a semicolon.